Moreover, blocking H4R in a model of pulmonary fibrosis alleviates the inflammatory response, reducing COX-2 expression and activity, leukocyte infiltration, TGF-β production, and collagen deposition (Lucarini et al., 2016). This evidence concerns the gene TGFB1 and pulmonary fibrosis.